First Time Loading...
N

Nong Woo Bio Co Ltd
KOSDAQ:054050

Watchlist Manager
Nong Woo Bio Co Ltd
KOSDAQ:054050
Watchlist
Price: 8 160 KRW -0.97%
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

135.8B
-5%
Revenue
Growth Rates:
1 Year
+2%
3 Years
+4%
5 Years
+31%
7 Years
+32%
10 Years
+63%
8.9B
-36%
Operating Income
Growth Rates:
1 Year
-20%
3 Years
+113%
5 Years
+72%
7 Years
-34%
10 Years
-26%
10.3B
-9%
Net Income
Growth Rates:
1 Year
+5%
3 Years
+10%
5 Years
-64%
7 Years
-
10 Years
-13%

Earnings Waterfall
Nong Woo Bio Co Ltd

Revenue
135.8B KRW
Cost of Revenue
-69.7B KRW
Gross Profit
66.2B KRW
Operating Expenses
-57.2B KRW
Operating Income
8.9B KRW
Other Expenses
1.4B KRW
Net Income
10.3B KRW

Income Statement
Nong Woo Bio Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
83 407
N/A
89 639
+7%
89 757
+0%
89 317
0%
87 510
-2%
84 005
-4%
89 054
+6%
96 841
+9%
18 896
-80%
102 165
+441%
103 870
+2%
95 480
-8%
103 089
+8%
102 598
0%
102 357
0%
101 094
-1%
104 456
+3%
101 968
-2%
108 031
+6%
107 237
-1%
104 027
-3%
107 819
+4%
111 535
+3%
116 344
+4%
121 267
+4%
125 372
+3%
128 206
+2%
129 894
+1%
130 030
+0%
129 180
-1%
131 650
+2%
130 325
-1%
132 843
+2%
136 466
+3%
137 434
+1%
146 292
+6%
133 400
-9%
146 239
+10%
141 777
-3%
143 678
+1%
135 844
-5%
Gross Profit
Cost of Revenue
(35 308)
(38 850)
(39 406)
(38 202)
(37 723)
(36 449)
(36 759)
(40 130)
(6 321)
(41 174)
(44 488)
(41 673)
(47 191)
(46 788)
(44 763)
(45 626)
(48 378)
(47 681)
(54 788)
(52 085)
(49 175)
(52 063)
(52 572)
(58 939)
(62 702)
(63 471)
(66 329)
(65 580)
(70 289)
(68 577)
(70 394)
(70 664)
(69 640)
(70 993)
(74 070)
(78 056)
(67 807)
(78 326)
(72 369)
(72 828)
(69 662)
Gross Profit
48 100
N/A
50 790
+6%
50 351
-1%
51 115
+2%
49 786
-3%
47 555
-4%
52 295
+10%
56 711
+8%
12 575
-78%
60 990
+385%
59 381
-3%
53 806
-9%
55 897
+4%
55 809
0%
57 593
+3%
55 467
-4%
56 078
+1%
54 288
-3%
53 245
-2%
55 154
+4%
54 852
-1%
55 757
+2%
58 963
+6%
57 405
-3%
58 565
+2%
61 901
+6%
61 877
0%
64 314
+4%
59 741
-7%
60 603
+1%
61 256
+1%
59 661
-3%
63 203
+6%
65 473
+4%
63 365
-3%
68 236
+8%
65 593
-4%
67 913
+4%
69 409
+2%
70 850
+2%
66 181
-7%
Operating Income
Operating Expenses
(35 981)
(36 693)
(35 957)
(35 873)
(39 425)
(44 740)
(45 662)
(44 181)
(11 819)
(40 259)
(41 792)
(40 712)
(42 429)
(44 048)
(43 657)
(45 651)
(46 126)
(46 787)
(48 182)
(48 244)
(49 665)
(50 663)
(51 629)
(53 890)
(54 634)
(55 597)
(56 577)
(55 566)
(55 546)
(58 099)
(59 487)
(59 403)
(56 379)
(56 682)
(57 931)
(60 236)
(54 462)
(59 998)
(57 147)
(56 850)
(57 237)
Selling, General & Administrative
(24 103)
(24 153)
(23 571)
(23 277)
(25 097)
(30 107)
(30 994)
(30 929)
(7 881)
(26 774)
(28 246)
(27 688)
(28 717)
(29 728)
(29 863)
(31 568)
(31 605)
(32 729)
(33 571)
(32 934)
(33 978)
(33 818)
(34 067)
(35 820)
(36 661)
(37 682)
(38 325)
(37 622)
(37 021)
(39 245)
(40 457)
(39 845)
(37 660)
(37 929)
(38 008)
(40 991)
(35 603)
(39 608)
(38 108)
(37 585)
(37 923)
Research & Development
(10 234)
(10 782)
(10 760)
(10 747)
(10 795)
(11 118)
(11 109)
(11 192)
(3 438)
(11 406)
(11 535)
(11 109)
(11 863)
(12 304)
(11 988)
(12 165)
(12 472)
(11 781)
(12 359)
(13 132)
(13 513)
(14 495)
(15 092)
(15 395)
(15 213)
(15 536)
(16 160)
(16 018)
(16 786)
(16 901)
(16 890)
(17 456)
(16 655)
(16 560)
(16 576)
(16 991)
(16 732)
(16 824)
(16 805)
(16 967)
(16 935)
Depreciation & Amortization
(1 644)
(1 670)
(1 626)
(1 849)
(1 939)
(1 921)
(1 965)
(2 060)
(500)
(2 079)
(2 012)
(1 916)
(1 849)
(1 789)
(1 805)
(1 916)
(2 048)
(2 112)
(2 203)
(2 178)
(2 174)
(2 349)
(2 469)
(2 674)
(2 760)
(2 382)
(2 094)
(1 930)
(1 739)
(1 944)
(2 131)
(2 092)
(2 064)
(2 193)
(2 204)
(2 254)
(2 127)
(2 323)
(2 234)
(2 380)
(2 379)
Other Operating Expenses
0
(88)
0
0
(1 594)
(1 594)
(1 594)
0
0
0
0
0
0
(227)
0
0
0
(165)
(49)
0
0
0
0
0
0
3
0
4
0
(9)
(9)
(10)
0
0
(1 143)
0
0
(1 243)
0
82
0
Operating Income
12 120
N/A
14 098
+16%
14 395
+2%
15 241
+6%
10 360
-32%
2 814
-73%
6 632
+136%
12 530
+89%
756
-94%
20 732
+2 642%
17 590
-15%
13 095
-26%
13 469
+3%
11 762
-13%
13 937
+18%
9 817
-30%
9 952
+1%
7 500
-25%
5 061
-33%
6 908
+36%
5 187
-25%
5 092
-2%
7 332
+44%
3 514
-52%
3 931
+12%
6 303
+60%
5 300
-16%
8 747
+65%
4 195
-52%
2 504
-40%
1 769
-29%
258
-85%
6 824
+2 542%
8 791
+29%
5 433
-38%
8 000
+47%
11 131
+39%
7 915
-29%
12 262
+55%
14 000
+14%
8 945
-36%
Pre-Tax Income
Interest Income Expense
347
125
(437)
585
1 160
1 150
1 770
2 094
(489)
481
93
(1 559)
534
(319)
(28)
646
(2 067)
(1 223)
(1 183)
(1 903)
18
562
311
1 522
(493)
(563)
(1 187)
(2 435)
1 670
(2 363)
(1 860)
(81)
881
377
1 057
1 881
(827)
(727)
(1 418)
(2 743)
(158)
Non-Reccuring Items
(88)
0
(88)
(1 631)
0
0
0
0
0
0
(228)
(228)
(228)
0
(114)
(114)
(164)
0
0
(50)
0
0
0
0
2
0
0
0
(9)
0
0
0
(1 144)
(1 143)
0
(1 143)
(1 241)
0
(1 514)
(1 514)
(774)
Gain/Loss on Disposition of Assets
(140)
80
434
678
652
561
208
10
0
16
162
161
171
176
65
63
142
110
615
767
534
535
37
(114)
313
315
154
357
67
0
240
60
64
535
940
526
523
143
(87)
458
1 016
Total Other Income
(221)
(35)
57
544
864
1 088
925
606
311
921
1 196
1 162
1 643
1 350
1 407
1 617
1 213
1 563
1 791
2 376
1 821
1 554
1 535
1 466
2 159
2 134
2 014
1 865
1 847
6 557
5 887
5 533
957
730
1 190
1 593
1 226
1 687
1 468
1 465
952
Pre-Tax Income
12 016
N/A
14 267
+19%
14 360
+1%
15 417
+7%
13 037
-15%
5 614
-57%
9 537
+70%
15 240
+60%
579
-96%
22 152
+3 726%
18 813
-15%
12 631
-33%
15 589
+23%
12 969
-17%
15 266
+18%
12 027
-21%
9 076
-25%
7 950
-12%
6 283
-21%
8 098
+29%
7 561
-7%
7 743
+2%
9 215
+19%
6 388
-31%
5 912
-7%
8 189
+39%
6 281
-23%
8 534
+36%
7 770
-9%
6 698
-14%
6 035
-10%
5 771
-4%
7 581
+31%
9 290
+23%
8 621
-7%
10 857
+26%
10 812
0%
9 019
-17%
10 711
+19%
11 666
+9%
9 980
-14%
Net Income
Tax Provision
(121)
(1 122)
(732)
(1 158)
(838)
504
694
937
(54)
(1 804)
(2 534)
(2 701)
(23 137)
(22 120)
(22 530)
(21 343)
153
21 021
21 838
21 452
21 088
594
230
897
1 073
640
1 052
547
1 687
2 282
1 701
1 468
(628)
(1 300)
(525)
(871)
(926)
(458)
(441)
(518)
188
Income from Continuing Operations
11 897
13 147
13 630
14 260
12 199
6 118
10 230
16 177
525
20 348
16 279
9 930
(7 548)
(9 150)
(7 264)
(9 315)
9 229
28 969
28 120
29 548
28 649
8 338
9 446
7 286
6 986
8 828
7 332
9 080
9 456
8 980
7 736
7 239
6 953
7 989
8 096
9 986
9 886
8 560
10 270
11 148
10 169
Income to Minority Interest
36
47
53
41
27
(1)
(10)
(21)
(14)
(18)
(13)
2
0
(13)
(40)
(75)
78
161
134
157
15
(38)
(18)
10
(1)
(83)
(67)
(67)
(56)
(13)
(2)
(25)
(23)
(3)
0
(5)
58
24
103
162
11
Net Income (Common)
11 931
N/A
13 192
+11%
13 682
+4%
14 300
+5%
12 226
-15%
6 118
-50%
10 221
+67%
16 157
+58%
511
-97%
20 329
+3 878%
16 265
-20%
9 931
-39%
(7 548)
N/A
(9 163)
-21%
(7 303)
+20%
(9 390)
-29%
9 307
N/A
29 130
+213%
28 253
-3%
29 705
+5%
28 664
-4%
8 299
-71%
9 427
+14%
7 295
-23%
6 984
-4%
8 746
+25%
7 266
-17%
9 015
+24%
9 400
+4%
8 969
-5%
7 735
-14%
7 215
-7%
6 930
-4%
7 986
+15%
8 097
+1%
9 981
+23%
9 879
-1%
8 584
-13%
10 406
+21%
11 344
+9%
10 333
-9%
EPS (Diluted)
852.21
N/A
942.28
+11%
977.28
+4%
1 021.42
+5%
873.28
-15%
437
-50%
730.07
+67%
1 154.07
+58%
36.5
-97%
1 452.07
+3 878%
1 161.78
-20%
709.35
-39%
-539.14
N/A
-654.5
-21%
-521.64
+20%
-670.71
-29%
664.78
N/A
2 080.71
+213%
1 765.81
-15%
1 856.56
+5%
1 910.93
+3%
518.68
-73%
589.18
+14%
455.93
-23%
436.5
-4%
546.62
+25%
454.12
-17%
563.43
+24%
587.5
+4%
559.05
-5%
482.54
-14%
450.08
-7%
432.32
-4%
498.18
+15%
505.08
+1%
622.6
+23%
616.24
-1%
535.5
-13%
649.16
+21%
707.63
+9%
644.55
-9%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.